scholarly journals 108. PREVENT: A Randomized Controlled Trial for the Prevention of First-Episode Psychosis Comparing Cognitive–Behavior Therapy (CBT), Clinical Management, and Aripiprazole Combined and Clinical Management and Placebo Combined

2017 ◽  
Vol 43 (suppl_1) ◽  
pp. S56-S57 ◽  
Author(s):  
Andreas Bechdolf ◽  
Hendrik Müller ◽  
Hartmut Stützer ◽  
Martin Lambert ◽  
Anne Karow ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Clinical Management ◽  
Controlled Trial ◽  
First Episode Psychosis ◽  
First Episode ◽  
Cognitive Behavior ◽  
Randomized Controlled ◽  
Episode Psychosis

scholarly journals The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first‐episode psychosis services

2021 ◽  
Vol 20 (2) ◽  
pp. 233-243
Author(s):  
Mario Alvarez‐Jimenez ◽  
Peter Koval ◽  
Lianne Schmaal ◽  
Sarah Bendall ◽  
Shaunagh O'Sullivan ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Treatment Effects ◽  
Controlled Trial ◽  
First Episode Psychosis ◽  
First Episode ◽  
Social Therapy ◽  
Randomized Controlled ◽  
Episode Psychosis

Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong

2016 ◽  
Vol 173 (1-2) ◽  
pp. 79-83 ◽  
Author(s):  
Wing Chung Chang ◽  
Vivian Wing Yan Kwong ◽  
Gloria Hoi Kei Chan ◽  
Olivia Tsz Ting Jim ◽  
Emily Sin Kei Lau ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Hong Kong ◽  
Early Intervention ◽  
Controlled Trial ◽  
First Episode Psychosis ◽  
First Episode ◽  
Randomized Controlled ◽  
Episode Psychosis

A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients

2009 ◽  
Vol 70 (4) ◽  
pp. 477-486 ◽  
Author(s):  
John F. M. Gleeson ◽  
Sue M. Cotton ◽  
Mario Alvarez-Jimenez ◽  
Darryl Wade ◽  
Donna Gee ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Relapse Prevention ◽  
Controlled Trial ◽  
First Episode Psychosis ◽  
First Episode ◽  
Randomized Controlled ◽  
Prevention Therapy ◽  
Episode Psychosis

Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial

2017 ◽  
Vol 35 (19) ◽  
pp. 2173-2183 ◽  
Author(s):  
Marieke van de Wal ◽  
Belinda Thewes ◽  
Marieke Gielissen ◽  
Anne Speckens ◽  
Judith Prins
Keyword(s):  
Colorectal Cancer ◽  
Randomized Controlled Trial ◽  
Cancer Survivors ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Controlled Trial ◽  
Cognitive Behavior ◽  
Cancer Worry ◽  
Randomized Controlled ◽  
Clinically Significant

Purpose Fear of cancer recurrence (FCR) is a common problem experienced by cancer survivors. Approximately one third of survivors report high FCR. This study aimed to evaluate whether blended cognitive behavior therapy (bCBT) can reduce the severity of FCR in cancer survivors curatively treated for breast, prostate, or colorectal cancer. Patients and Methods This randomized controlled trial included 88 cancer survivors with high FCR (Cancer Worry Scale score ≥ 14) from 6 months to 5 years after cancer treatment. Participants were randomly allocated (ratio 1:1, stratified by cancer type) to receive bCBT, including five face-to face and three online sessions (n = 45) or care as usual (CAU; n = 43). Participants completed questionnaires at baseline (T0) and 3 months later (T1). The intervention group completed bCBT between T0 and T1. The primary outcome was FCR severity assessed with the Cancer Worry Scale. Secondary outcomes included other distress-related measures. Statistical (one-way between-group analyses of covariance) and clinical effects (clinically significant improvement) were analyzed by intention to treat. Results Participants who received bCBT reported significantly less FCR than those who received CAU (mean difference, –3.48; 95% CI, –4.69 to –2.28; P < .001) with a moderate-to-large effect size ( d = 0.76). Clinically significant improvement in FCR was significantly higher in the bCBT group than in the CAU group (13 [29%] of 45 compared with 0 [0%] of 43; P < .001); self-rated improvement was also higher in the bCBT group (30 [71%] of 42 compared with 12 [32%] of 38 in the CAU group; P < .001). Conclusion bCBT has a statistically and clinically significant effect on the severity of FCR in cancer survivors and is a promising new treatment approach.

scholarly journals A Randomized Controlled Trial of Bibliotherapy for Carers of Young People With First-Episode Psychosis

2012 ◽  
Vol 39 (6) ◽  
pp. 1307-1317 ◽  
Author(s):  
Terence V. McCann ◽  
Dan I. Lubman ◽  
Sue M. Cotton ◽  
Brendan Murphy ◽  
Kingsley Crisp ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Young People ◽  
Controlled Trial ◽  
First Episode Psychosis ◽  
First Episode ◽  
Randomized Controlled ◽  
Episode Psychosis

scholarly journals Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Nicholas JK Breitborde ◽  
Francisco A Moreno ◽  
Natalie Mai-Dixon ◽  
Rachele Peterson ◽  
Linda Durst ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Cognitive Remediation ◽  
First Episode Psychosis ◽  
First Episode ◽  
Randomized Controlled ◽  
Episode Psychosis ◽  
Group Psychoeducation
Sign in / Sign up

Export Citation Format

Share Document